These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
381 related articles for article (PubMed ID: 32075932)
1. Neutralization Mechanism of a Monoclonal Antibody Targeting a Porcine Circovirus Type 2 Cap Protein Conformational Epitope. Huang L; Sun Z; Xia D; Wei Y; Sun E; Liu C; Zhu H; Bian H; Wu H; Feng L; Wang J; Liu C J Virol; 2020 Apr; 94(9):. PubMed ID: 32075932 [TBL] [Abstract][Full Text] [Related]
2. A broad spectrum monoclonal antibody against porcine circovirus type 2 for antigen and antibody detection. Huang L; Wei Y; Xia D; Liu D; Zhu H; Wu H; Feng L; Liu C Appl Microbiol Biotechnol; 2019 Apr; 103(8):3453-3464. PubMed ID: 30863876 [TBL] [Abstract][Full Text] [Related]
3. Identification of one critical amino acid that determines a conformational neutralizing epitope in the capsid protein of porcine circovirus type 2. Huang LP; Lu YH; Wei YW; Guo LJ; Liu CM BMC Microbiol; 2011 Aug; 11():188. PubMed ID: 21859462 [TBL] [Abstract][Full Text] [Related]
4. A chimeric virus created by DNA shuffling of the capsid genes of different subtypes of porcine circovirus type 2 (PCV2) in the backbone of the non-pathogenic PCV1 induces protective immunity against the predominant PCV2b and the emerging PCV2d in pigs. Matzinger SR; Opriessnig T; Xiao CT; Catanzaro N; Beach NM; Slade DE; Nitzel GP; Meng XJ Virology; 2016 Nov; 498():82-93. PubMed ID: 27564544 [TBL] [Abstract][Full Text] [Related]
5. Amino acid mutations in the capsid protein produce novel porcine circovirus type 2 neutralizing epitopes. Liu J; Huang L; Wei Y; Tang Q; Liu D; Wang Y; Li S; Guo L; Wu H; Liu C Vet Microbiol; 2013 Aug; 165(3-4):260-7. PubMed ID: 23582511 [TBL] [Abstract][Full Text] [Related]
6. The Carboxyl Terminus of the Porcine Circovirus Type 2 Capsid Protein Is Critical to Virus-Like Particle Assembly, Cell Entry, and Propagation. Zhan Y; Yu W; Cai X; Lei X; Lei H; Wang A; Sun Y; Wang N; Deng Z; Yang Y J Virol; 2020 Apr; 94(9):. PubMed ID: 32075927 [TBL] [Abstract][Full Text] [Related]
7. Capsid proteins from PCV2a genotype confer greater protection against a PCV2b strain than those from PCV2b genotype in pigs: evidence for PCV2b strains becoming more predominant than PCV2a strains from 2000 to 2010s. Huang L; Wang Y; Wei Y; Chen D; Liu D; Du W; Xia D; Wu H; Feng L; Liu C Appl Microbiol Biotechnol; 2016 Jul; 100(13):5933-43. PubMed ID: 27020283 [TBL] [Abstract][Full Text] [Related]
8. Structural roles of PCV2 capsid protein N-terminus in PCV2 particle assembly and identification of PCV2 type-specific neutralizing epitope. Mo X; Li X; Yin B; Deng J; Tian K; Yuan A PLoS Pathog; 2019 Mar; 15(3):e1007562. PubMed ID: 30822338 [TBL] [Abstract][Full Text] [Related]
9. Genetic diversity and different cross-neutralization capability of porcine circovirus type 2 isolates recently circulating in South Korea. Kang SJ; Kang H; You SH; Lee HJ; Lee N; Hyun BH; Cha SH BMC Vet Res; 2020 Sep; 16(1):334. PubMed ID: 32928247 [TBL] [Abstract][Full Text] [Related]
10. T cell epitope content comparison (EpiCC) analysis demonstrates a bivalent PCV2 vaccine has greater T cell epitope overlap with field strains than monovalent PCV2 vaccines. Bandrick M; Gutiérrez AH; Desai P; Rincon G; Martin WD; Terry FE; De Groot AS; Foss DL Vet Immunol Immunopathol; 2020 May; 223():110034. PubMed ID: 32278900 [TBL] [Abstract][Full Text] [Related]
11. A novel strategy for an anti-idiotype vaccine: nanobody mimicking neutralization epitope of porcine circovirus type 2. Deng Y; Sheng Y; Zhang G; Sun Y; Wang L; Ji P; Zhu J; Wang G; Liu B; Zhou E-M; Cai X; Tu Y; Hiscox JA; Stewart JP; Mu Y; Zhao Q J Virol; 2024 Feb; 98(2):e0165023. PubMed ID: 38271227 [TBL] [Abstract][Full Text] [Related]
12. A Porcine circovirus type 2b (PCV2b)-based experimental vaccine is effective in the PCV2b-Mycoplasma hyopneumoniae coinfection pig model. Opriessnig T; Castro AMMG; Karuppanan AK; Gauger PC; Halbur PG; Matzinger SR; Meng XJ Vaccine; 2019 Oct; 37(44):6688-6695. PubMed ID: 31537445 [TBL] [Abstract][Full Text] [Related]
13. Structural insight into the type-specific epitope of porcine circovirus type 3. Bi M; Li X; Zhai W; Yin B; Tian K; Mo X Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32458997 [TBL] [Abstract][Full Text] [Related]
14. Early antibody responses map to non-protective, PCV2 capsid protein epitopes. Ilha M; Nara P; Ramamoorthy S Virology; 2020 Jan; 540():23-29. PubMed ID: 31734380 [TBL] [Abstract][Full Text] [Related]
15. A candidate DNA vaccine encoding a fusion protein of porcine complement C3d-P28 and ORF2 of porcine circovirus type 2 induces cross-protective immunity against PCV2b and PCV2d in pigs. Hou Z; Wang H; Feng Y; Li Q; Li J Virol J; 2019 May; 16(1):57. PubMed ID: 31046793 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of a porcine circovirus type 2a (PCV2a) vaccine efficacy against experimental PCV2a, PCV2b, and PCV2d challenge. Park KH; Oh T; Yang S; Cho H; Kang I; Chae C Vet Microbiol; 2019 Apr; 231():87-92. PubMed ID: 30955830 [TBL] [Abstract][Full Text] [Related]
17. Porcine circovirus type 2a or 2b based experimental vaccines provide protection against PCV2d/porcine parvovirus 2 co-challenge. Opriessnig T; Karuppannan AK; Halbur PG; Calvert JG; Nitzel GP; Matzinger SR; Meng XJ Vaccine; 2020 Feb; 38(8):1975-1981. PubMed ID: 31974016 [TBL] [Abstract][Full Text] [Related]
18. Generation in yeast of recombinant virus-like particles of porcine circovirus type 2 capsid protein and their use for a serologic assay and development of monoclonal antibodies. Nainys J; Lasickiene R; Petraityte-Burneikiene R; Dabrisius J; Lelesius R; Sereika V; Zvirbliene A; Sasnauskas K; Gedvilaite A BMC Biotechnol; 2014 Dec; 14():100. PubMed ID: 25487652 [TBL] [Abstract][Full Text] [Related]
19. Antigenic subtyping and epitopes' competition analysis of porcine circovirus type 2 using monoclonal antibodies. Saha D; Huang L; Bussalleu E; Lefebvre DJ; Fort M; Van Doorsselaere J; Nauwynck HJ Vet Microbiol; 2012 May; 157(1-2):13-22. PubMed ID: 22176764 [TBL] [Abstract][Full Text] [Related]
20. Replacing the decoy epitope of PCV2 capsid protein with epitopes of GP3 and/or GP5 of PRRSV enhances the immunogenicity of bivalent vaccines in mice. Jung BK; Kim HR; Jang H; Chang KS J Virol Methods; 2020 Oct; 284():113928. PubMed ID: 32650038 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]